Elizabeth E. Reed, SVP, GC & Corporate Secretary at Travere Therapeutics, Inc. (TVTX), sold 2,062 shares at $21.50 ($44K) on 2023-01-24, disclosed to the SEC on 2023-01-26.
Scheduled sale ($44k) by SVP, GC & Corporate Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TVTX | SELL | 2026-04-15 | $2.1M | — | Filing → |
| TVTX | SELL | 2026-04-02 | $300K | — | Filing → |
| TVTX | SELL | 2026-03-18 | $562K | — | Filing → |